Skip to main content
Fig. 1 | Arthritis Research & Therapy

Fig. 1

From: Semaphorin 7A as a potential immune regulator and promising therapeutic target in rheumatoid arthritis

Fig. 1

Levels of soluble semaphorin 7A (sSema7A) and correlation with markers of rheumatoid arthritis (RA) disease activity. a sSema7A levels in serum and synovial fluid samples from patients with RA and patients with osteoarthritis (OA). b Serum sSema7A levels before and after biologic disease-modifying antirheumatic drug treatment in good responders according to the European League Against Rheumatism response criteria. Values in a and b are mean ± SD. **P < 0.01; ***P < 0.001. N.S Not significant. c Correlation between serum sSema7A levels with rheumatoid factor (RF) titer, Disease Activity Score in 28 joints (DAS28), and C-reactive protein (CRP) level (n = 31 samples)

Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us